Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 An overview of the status of the nitrosoureas in other tumors.

× No keyword cloud information.

11 in total

1. Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.

Authors: M Hayat; C Bourut; E Chenu; J L Montero; J L Imbach; J S MacDonald; G Mathé
Journal: Cancer Chemother Pharmacol Date: 1979 Impact factor: 3.333

Review 2. Antineoplastic drugs in 1990. A review (Part II).

Authors: D J Black; R B Livingston
Journal: Drugs Date: 1990-05 Impact factor: 9.546

3. Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU.

Authors: L C Panasci; M Dufour; L Chevalier; G Isabel; P Lazarus; A McQuillan; E Arbit; S Brem; W Feindel
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

4. Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation.

Authors: J L Misset; G Mathé; M Tubiana; B Caillou; F de Vassal; P Pouillart; M Gil; C Tentas; M Hayat; L Schwarzenberg; C Jasmin; M Delgado; D Machover; P Ribaud; M Musset
Journal: Cancer Chemother Pharmacol Date: 1978 Impact factor: 3.333

5. Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts.

Authors: A Malapetsa; J L Bramson; A J Noë; L C Panasci
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

6. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.

Authors: L C Panasci; D Green; P S Schein
Journal: J Clin Invest Date: 1979-10 Impact factor: 14.808

7. Cytostatic action of two nitrosoureas derived from cysteamine.

Authors: C Bourut; E Chenu; D Godenèche; J C Madelmont; R Maral; G Mathé; G Meyniel
Journal: Br J Pharmacol Date: 1986-11 Impact factor: 8.739

8. Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice.

Authors: R I Fisher; G L Mandell; F Bostick; M G McMenamin; T Anderson
Journal: Clin Exp Immunol Date: 1980-02 Impact factor: 4.330

9. Comparison of the transport of chlorozotocin and CCNU in L1210 leukemia and murine bone marrow cells in vitro.

Authors: P Lazarus; J S Germina; M Dufour; G Palmer; D Wallace; L C Panasci
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333

10. Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.

Authors: G Sava; T Giraldi
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333